Adze Biotechnology Inc

Amendment
CIK: 0001787508·Biotechnology·DELAWARE·Filed: Feb 19, 2025
Total Offering

$15,000,000

Amount Sold

$6,149,998

Investors

21

First Sale

Mar 10, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Gloria Olivier
Related Person
Gabriel Raviv
Related Person
G. Patrick Sage, II
Related Person
Kenneth J. Templin
Related Person
Sidney Hopps
Related Person
Brendan Kenny
Related Person

Company

Adze Biotechnology Inc

2332 Galiano Street, 2nd Fl

Coral Gables, FL, 33134

9177439401

SEC Filing

0001787508-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free